ERBB2 and breast cancer: The analysis of specific gene expression changes in each BC subtype showed that in luminal (HR+ HER2− BC, the most frequent subtype of BC, the expression of miR-200c-3p was associated with a profile characterized by enhanced proliferation, the significant inhibition of VIM and higher expression of both CDH1 and ESR1.